Literature DB >> 8375859

Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: a clinicopathologic review of 16 cases.

K H Anders1, P S Becker, J K Holden, L R Sharer, M E Cornford, L A Hansen, R Hamilton, H V Vinters.   

Abstract

Multifocal necrotizing leukoencephalopathy (MNL) is characterized by multiple, usually microscopic, foci of necrosis confined primarily to the white matter of the basis pontis, but sometimes found elsewhere in the central nervous system. All 16 patients in whom we identified MNL had underlying immunosuppression, either naturally occurring or iatrogenic, including the acquired immunodeficiency syndrome (seven patients), acute leukemias (four patients), and lymphoma (one patient). One patient each had severe combined immunodeficiency, orthotopic liver transplantation, Shwachman-Diamond syndrome, and idiopathic thrombocytopenic purpura treated with high-dose steroids. Histologically, lesions of MNL show demyelination, spongiosis, axonal swelling, minimal histiocytic infiltrates, and frequent axonal calcification. Multifocal necrotizing leukoencephalopathy lesions were found in the pons of all patients, most commonly in the crossing pontocerebellar fibers, but often in the descending white matter tracts and rarely in the tegmentum. Three cases also showed nonpontine foci of MNL involving the white matter of the medulla, cerebellum, and cerebral hemispheres. Multifocal necrotizing leukoencephalopathy is a distinct entity usually localized to the basis pontis and is most consistently associated with immunosuppression, but as yet lacks other clearly defined clinical correlates.

Entities:  

Mesh:

Year:  1993        PMID: 8375859     DOI: 10.1016/0046-8177(93)90140-c

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Pontocerebellar contribution to postural instability and psychomotor slowing in HIV infection without dementia.

Authors:  Edith V Sullivan; Margaret J Rosenbloom; Torsten Rohlfing; Carol A Kemper; Stanley Deresinski; Adolf Pfefferbaum
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

2.  Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy.

Authors:  T Dianne Langford; Scott L Letendre; Thomas D Marcotte; Ronald J Ellis; J Allen McCutchan; Igor Grant; Margaret E Mallory; Lawrence A Hansen; Sarah Archibald; Terry Jernigan; Eliezer Masliah
Journal:  AIDS       Date:  2002-05-03       Impact factor: 4.177

3.  White matter cellular changes in ischemic injuries.

Authors:  Murad Alturkustani; Lee-Cyn Ang
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

4.  Multifocal Necrotizing Leukoencephalopathy With Preferential Microglia Toxicity in a Patient Treated With Chimeric Antigen Receptor T-Cells and Review of the Literature.

Authors:  Daniel F Marker; Julia K Kofler; Joseph A Mettenburg; Mounzer E Agha; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2020-10-01       Impact factor: 3.685

5.  Disseminated Necrotizing Leukoencephalopathy Complicating Septic Shock in an Immunocompetent Patient.

Authors:  Pedro Gaspar-da-Costa; Sofia Reimão; Sandra Braz; João Meneses Santos; Rui M M Victorino
Journal:  Case Rep Crit Care       Date:  2017-04-24

6.  Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.

Authors:  Imke Metz; Peter Rieckmann; Boris-Alexander Kallmann; Wolfgang Brück
Journal:  Acta Neuropathol Commun       Date:  2016-08-08       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.